A new tool developed by researchers can estimate how fast someone is aging by analyzing a single MRI brain scan, predicting ...

Smaller, shallow brain folds in the posteromedial cortex show greater thinning with age and Alzheimer’s disease, and their ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Remarkable new findings about the sugar stores in neurons have unlocked an entire new method of treating Alzheimer's disease ...

For patients with MCI associated with Alzheimer disease, those in the highest tertile of the triglyceride-glucose index experience faster cognitive decline.

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...

Cognito Therapeutics has reached its enrolment goal for the HOPE Study investigating the Spectris AD system for Alzheimer's disease (AD).

Alzheimer's may represent a form of brain-specific diabetes, with insulin resistance linking it to type 2 diabetes and ...

New research proposes a unified theory of brain function based on criticality—a state where the brain teeters between order ...

Cognito Therapeutics Completes Enrollment in HOPE Pivotal Study of Spectris™ AD Therapy for the Treatment of Patients with Alzheimer’s Disease ...

New indication added for selection of patients for amyloid-directed therapiesQuantitative image analysis addedPrevious limitations of use removed Amyloid, a naturally occurring protein, can accumulate ...